PD-L1 immunohistochemical assays for assessment of therapeutic strategies involving immune checkpoint inhibitors in non-small cell lung cancer: a comparative study
Hyojin Kim(Seoul National University), Jin-Haeng Chung(Seoul National University)
Cited by 51
Related Papers
The new 2023 FIGO staging system for endometrial cancer: what is different from the previous 2009 FIGO staging system?
|Journal of Gynecologic Oncology|2024|25